1026650--3/3/2010--ERESEARCHTECHNOLOGY_INC

related topics

{regulation, government, change}

{customer, product, revenue}

{property, intellectual, protect}

{product, market, service}

{control, financial, internal}

{stock, price, share}

{tax, income, asset}

If general economic conditions deteriorate or fail to improve, potential clients may be unable to get the necessary financing to conduct business and existing clients may fail to make timely payments for services that we have performed, which could adversely affect our ability to maintain or increase overall revenues and our overall financial position. Extensive governmental regulation of the clinical trial process could require costly modifications to our technology, adversely affect prospective clients willingness to use our service solutions and increase competition and reduce our market share. We have clients from whom we derive substantial revenue and therefore the loss of even a few of our clients could significantly reduce our revenues and profitability. Our business could be seriously harmed by our dependence on a limited number of suppliers. Rapidly changing technology may impair our ability to develop and market our solutions and cause us to become less competitive. If we are unable to protect our proprietary technology or maintain our technological advantages, we may lose our intellectual property rights and become less competitive. Goodwill is subject to impairment which could result in a significant expense. In the event we are unable to satisfy regulatory requirements relating to internal control over financial reporting, or if these internal controls are not effective, our business and financial results may suffer. The market price and trading volume of our common stock may be volatile, which could result in substantial losses for investors purchasing shares in the public markets and subject us to securities class action litigation. The current market price of our common stock may not be indicative of future market prices and we may be unable to sustain or increase the value of an investment in our common stock.

Full 10-K form ▸

1026650--3/3/2010--ERESEARCHTECHNOLOGY_INC_/DE/